Active, not recruitingNCT04156997
Extreme Lipids Repository
Studying Disorder of lipid absorption and transport
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Texas Southwestern Medical Center
- Principal Investigator
- Anand Rohatgi, MD, MDUniversity of Texas Southwestern Medical Center
- Intervention
- No intervention is involved in this study(other)
- Enrollment
- 250 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2019 – 2029
Study locations (2)
- Parkland Health Hospital System, Dallas, Texas, United States
- University of Texas Southwestern Medical Center - Ambulatory Clinic, Dallas, Texas, United States
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04156997 on ClinicalTrials.govOther trials for Disorder of lipid absorption and transport
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07235046A Study of DII235 in Adults With Elevated Lipoprotein(a)Novartis Pharmaceuticals
- RECRUITINGPHASE2NCT07327840Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a)Kylonova (Xiamen) Biopharma co., LTD.
- ACTIVE NOT RECRUITINGPHASE2NCT07185776A Study of HRS-5632 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular EventsFujian Shengdi Pharmaceutical Co., Ltd.
- RECRUITINGNCT07324902The Effect of Lipoprotein (a) on Arterial Stiffness, Endothelial Function and Myocardial DeformationUniversity of Athens
See all trials for Disorder of lipid absorption and transport →